 <h1>Mephobarbital Side Effects</h1><ul class="nav-tabs nav-tabs-collapse nav-tabs-pill">
<li><b class="nav-item here">Side Effects</b></li>
<li>Dosage</li>
<li>Professional</li>
<li>Interactions</li>
<li>Pregnancy</li>
<li>Reviews</li>
<li class="nav-more">
More&lt;svg aria-hidden="true" class="ddc-icon ddc-icon-down" focusable="false" height="16" viewbox="0 0 24 24" width="16" xmlns="http://www.w3.org/2000/svg"&gt;&lt;path d="M18.5 7.94L19.56 9 12 16.56 4.44 9 5.5 7.94l6.5 6.5z"&gt;&lt;/path&gt;&lt;/svg&gt;
</li>
</ul><ul>
<li>Managing Side Effects</li>
</ul><p><i>Applies to mephobarbital: oral tablet</i></p><h3>Nervous system</h3><p>Nervous system side effects including primarily somnolence (1% to 3%) have been reported.  Agitation, confusion, hyperkinesia, ataxia, CNS depression, nightmares, nervousness, psychiatric disturbance, hallucination, insomnia, anxiety, dizziness, and abnormal thinking have all been reported to occur in less than 1% of treated patients.  Headache has been reported with chronic use.<sup>[Ref]</sup></p><h3>Respiratory</h3><p>Respiratory side effects including hypoventilation and apnea have been reported to occur in less than 1% of treated patients.<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p>Cardiovascular side effects including bradycardia, hypotension, and syncope have been reported to occur in less than 1% of treated patients.<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p>Gastrointestinal side effects including nausea, vomiting, and constipation have been reported to occur in less than 1% of treated patients.<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p>Hypersensitivity side effects including angioedema, skin rashes, and exfoliative dermatitis have been reported to occur with chronic use in less than 1% of treated patients.<sup>[Ref]</sup></p><h3>General</h3><p>General side effects including fever have been reported to occur with chronic use in less than 1% of treated patients.<sup>[Ref]</sup></p><h3>Hepatic</h3><p>Hepatic side effects including liver damage have been reported to occur with chronic use in less than 1% of treated patients.<sup>[Ref]</sup></p><h3>Hematologic</h3><p>Hematologic side effects including megaloblastic anemia have been reported to occur with chronic use in less than 1% of treated patients.<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. Mebaral (mephobarbital)" Sanofi Winthrop Pharmaceuticals, New York, NY. </p><h2>More about mephobarbital</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>4 Reviews</li>
<li>Drug class: barbiturate anticonvulsants</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Seizure Prevention</li>
<li>Epilepsy</li>
<li>Sedation</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>